{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:27:11Z","timestamp":1791516431315,"version":"4.3.4"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274345"],"award-info":[{"award-number":["82274345"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012173","name":"China-Japan Friendship Hospital","doi-asserted-by":"publisher","award":["ZRJY2023-GG22"],"award-info":[{"award-number":["ZRJY2023-GG22"]}],"id":[{"id":"10.13039\/501100012173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ginseng Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jgr.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:17:35Z","timestamp":1739906255000},"page":"225-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Roles and mechanisms of ginsenoside Rg1 in coronary artery disease: Progress and perspectives"],"prefix":"10.1016","volume":"49","author":[{"given":"Lixiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3728-9170","authenticated-orcid":false,"given":"Ming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgr.2025.02.003_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2991\/jegh.k.201217.001","article-title":"Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review","volume":"11","author":"Ralapanawa","year":"2021","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.jgr.2025.02.003_bib2","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1056\/NEJMoa1909406","article-title":"Five-year outcomes after PCI or CABG for left main coronary disease","volume":"381","author":"Stone","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1142\/S0192415X23500507","article-title":"Pharmacological effects of ginseng: multiple constituents and multiple actions on humans","volume":"51","author":"Zhou","year":"2023","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1749-8546-5-20","article-title":"Pharmacology of ginsenosides: a literature review","volume":"5","author":"Leung","year":"2010","journal-title":"Chin Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030372","article-title":"Comparison of ginsenoside components of various tissues of New Zealand forest-grown asian ginseng (Panax ginseng) and American ginseng (Panax Quinquefolium L.)","volume":"10","author":"Chen","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jgr.2025.02.003_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jgr.2022.07.006","article-title":"Ginsenoside Rg1 ameliorates chronic intermittent hypoxia-induced vascular endothelial dysfunction by suppressing the formation of mitochondrial reactive oxygen species through the calpain-1 pathway","volume":"47","author":"Zhao","year":"2023","journal-title":"Journal of Ginseng Research"},{"key":"10.1016\/j.jgr.2025.02.003_bib7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jep.2011.09.029","article-title":"Ginsenoside Rg1 inhibits vascular intimal hyperplasia in balloon-injured rat carotid artery by down-regulation of extracellular signal-regulated kinase 2","volume":"138","author":"Gao","year":"2011","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jgr.2025.02.003_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3892\/etm.2022.11482","article-title":"Ginsenoside Rg1 ameliorates apoptosis, senescence and oxidative stress in ox-LDL-induced vascular endothelial cells via the AMPK\/SIRT3\/p53 signaling pathway","volume":"24","author":"Lyu","year":"2022","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bcp.2013.05.006","article-title":"MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2","volume":"86","author":"Chan","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jgr.2025.02.003_bib10","first-page":"69","article-title":"Ginsenoside Rg1 inhibits hypertrophy induced by Ang\u2161 in cardiac myocytes of neonatal rats via SIRT1\/PGC-1alpha signal pathway","volume":"35","author":"Sun","year":"2019","journal-title":"Pharmacology and Clinics of Chinese Materia Medica"},{"key":"10.1016\/j.jgr.2025.02.003_bib11","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jgr.2025.02.003_bib12","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib13","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJMc1915621","article-title":"Ticagrelor or prasugrel in acute coronary syndromes","volume":"382","author":"Carbonell-Prat","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jgr.2025.02.003_bib16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/hc0502.104540","article-title":"Fundamentals of endothelial function for the clinical cardiologist","volume":"105","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jgr.2025.02.003_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jgr.2025.02.003_bib18","first-page":"388","article-title":"Inhibitory effect of ginsenoside Rg1 on vascular neointimal hyperplasia induced by balloon-injury in rats and the relation to its anti-oxidant action and up-regulating eNOS expression","volume":"28","author":"Gao","year":"2012","journal-title":"Chin Pharmacol Bull"},{"key":"10.1016\/j.jgr.2025.02.003_bib19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4314\/tjpr.v12i6.12","article-title":"Evaluation of ginsenoside Rg1 as a potential antioxidant for preventing or ameliorating progression of atherosclerosis","volume":"12","author":"Huang","year":"2013","journal-title":"Trop J Pharmaceut Res"},{"key":"10.1016\/j.jgr.2025.02.003_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121972","article-title":"Ginsenoside Rg1 attenuates diabetic vascular endothelial dysfunction by inhibiting the calpain-1\/ROS\/PKC-\u03b2 axis","volume":"329","author":"Lu","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.jgr.2025.02.003_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.etap.2012.11.006","article-title":"Ginsenoside Rg1 reduces toxicity of PM(2.5) on human umbilical vein endothelial cells by upregulating intracellular antioxidative state","volume":"35","author":"Li","year":"2013","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.jgr.2025.02.003_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/157016112798829760","article-title":"The role of nitric oxide on endothelial function","volume":"10","author":"Tousoulis","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jgr.2025.02.003_bib23","first-page":"871","article-title":"Ginsenoside Rg1-induced alterations in gene expression in TNF-alpha stimulated endothelial cells","volume":"117","author":"L\u00fc","year":"2004","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jgr.2025.02.003_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.vph.2011.12.006","article-title":"Panax notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatation","volume":"56","author":"Pan","year":"2012","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jgr.2025.02.003_bib25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCRESAHA.117.311973","article-title":"Monocyte recruitment versus macrophage proliferation in atherosclerosis","volume":"121","author":"Kanter","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jgr.2025.02.003_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1142\/S0192415X15500202","article-title":"Ginsenoside Rg1 downregulates the shear stress induced MCP-1 expression by inhibiting MAPK signaling pathway","volume":"43","author":"He","year":"2015","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib27","first-page":"337","article-title":"Recent advances of phenotypic switch of vascular smooth muscle cells in vascular diseases","volume":"35","author":"Wen","year":"2023","journal-title":"Chinese Heart Journal"},{"key":"10.1016\/j.jgr.2025.02.003_bib28","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/jcb.20799","article-title":"Ginsenoside Rg1 inhibits tumor necrosis factor-alpha (TNF-alpha)-induced human arterial smooth muscle cells (HASMCs) proliferation","volume":"98","author":"Zhang","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jgr.2025.02.003_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/314395","article-title":"Inhibitory effect of ginsenoside Rg1 on vascular smooth muscle cell proliferation induced by PDGF-BB is involved in nitric oxide formation","volume":"2012","author":"Huang","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib30","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1745-7254.2006.00331.x","article-title":"Ginsenoside Rg1 inhibits proliferation of vascular smooth muscle cells stimulated by tumor necrosis factor-alpha","volume":"27","author":"Ma","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jgr.2025.02.003_bib31","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.jacc.2016.11.005","article-title":"Targeting inflammation in atherosclerosis","volume":"68","author":"Bentzon","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jgr.2025.02.003_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jgr.2021.04.006","article-title":"Longevity, tumor, and physical vitality in rats consuming ginsenoside Rg1","volume":"47","author":"Hsieh","year":"2023","journal-title":"Journal of Ginseng Research"},{"key":"10.1016\/j.jgr.2025.02.003_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.fitote.2013.09.001","article-title":"Ginsenoside Rg1 exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vitro","volume":"91","author":"Song","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jgr.2025.02.003_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.intimp.2014.07.028","article-title":"Ginsenoside Rg1 regulates innate immune responses in macrophages through differentially modulating the NF-\u03baB and PI3K\/Akt\/mTOR pathways","volume":"23","author":"Wang","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jgr.2025.02.003_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114920","article-title":"Ginsenoside Rg1 ameliorates hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and inflammation by regulating CCN1","volume":"164","author":"Tang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jgr.2025.02.003_bib36","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2147\/DMSO.S208989","article-title":"Ginsenoside Rg1 ameliorates cardiac oxidative stress and inflammation in streptozotocin-induced diabetic rats","volume":"12","author":"Qin","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jgr.2025.02.003_bib37","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jgr.2025.02.003_bib38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2020.5685","article-title":"Lipids and lipoproteins in 2020","volume":"324","author":"Ference","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jgr.2025.02.003_bib39","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1021\/acsomega.0c00529","article-title":"Ginsenoside Rg1 regulates liver lipid factor metabolism in NAFLD model rats","volume":"5","author":"Hou","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.jgr.2025.02.003_bib40","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11418-012-0713-4","article-title":"Increased effects of ginsenosides on the expression of cholesterol 7\u03b1-hydroxylase but not the bile salt export pump are involved in cholesterol metabolism","volume":"67","author":"Kawase","year":"2013","journal-title":"J Nat Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib41","doi-asserted-by":"crossref","first-page":"932","DOI":"10.5352\/JLS.2011.21.7.932","article-title":"Antihyperlipidemic effect of ginsenoside Rg1 in type 2 diabetic mice","volume":"21","author":"Jae Hong","year":"2011","journal-title":"Korean Journal of Life Science"},{"key":"10.1016\/j.jgr.2025.02.003_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/nu10070830","article-title":"Antiobesity effects of ginsenoside Rg1 on 3T3-L1 preadipocytes and high fat diet-induced obese mice mediated by AMPK","volume":"10","author":"Liu","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.jgr.2025.02.003_bib43","first-page":"864","article-title":"Ginsenoside Rg1 improves liver function by regulating fat metabolism in rats with non-alcoholic fatty liver disease","volume":"31","author":"Peng","year":"2015","journal-title":"Chin J Pathophysiol"},{"key":"10.1016\/j.jgr.2025.02.003_bib44","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jgr.2025.02.003_bib45","article-title":"Cardioprotection of Panax Notoginseng saponins against acute myocardial infarction and heart failure through inducing autophagy","volume":"136","author":"Dandan","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jgr.2025.02.003_bib46","first-page":"31","article-title":"The effect of rat platelet aggregation and platelet cyclic AMP metabolism by Ginsenoside Rg1","volume":"31","author":"Hua","year":"2012","journal-title":"Journal of Tianjin University of Traditional Chinese Medicine"},{"key":"10.1016\/j.jgr.2025.02.003_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.thromres.2013.10.032","article-title":"Ginsenoside Rg1 inhibits platelet activation and arterial thrombosis","volume":"133","author":"Zhou","year":"2014","journal-title":"Thromb Res"},{"issue":"12","key":"10.1016\/j.jgr.2025.02.003_bib48","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s12272-010-1213-2","article-title":"Pharmacokinetics, tissue distribution, metabolism, and excretion of ginsenoside Rg1 in rats","volume":"33","author":"Feng","year":"2010","journal-title":"Arch Pharm Res (Seoul)"},{"key":"10.1016\/j.jgr.2025.02.003_bib49","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/pca.3152","article-title":"Anticoagulant activity analysis and origin identification of Panax notoginseng using HPLC and ATR-FTIR spectroscopy","volume":"33","author":"Cui","year":"2022","journal-title":"Phytochem Anal"},{"key":"10.1016\/j.jgr.2025.02.003_bib50","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3109\/13880209.2013.775164","article-title":"A comparative study on anticoagulant activities of three Chinese herbal medicines from the genus Panax and anticoagulant activities of ginsenosides Rg1 and Rg2","volume":"51","author":"Li","year":"2013","journal-title":"Pharm Biol"},{"key":"10.1016\/j.jgr.2025.02.003_bib51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis","volume":"386","author":"Risau","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jgr.2025.02.003_bib52","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/bmj.318.7197.1536","article-title":"Therapeutic angiogenesis","volume":"318","author":"Henry","year":"1999","journal-title":"Bmj"},{"key":"10.1016\/j.jgr.2025.02.003_bib53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijpharm.2006.08.009","article-title":"Stability of angiogenic agents, ginsenoside Rg1 and Re, isolated from Panax ginseng: in vitro and in vivo studies","volume":"328","author":"Yu","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jgr.2025.02.003_bib54","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/01.CIR.0000140676.88412.CF","article-title":"Modulating angiogenesis: the yin and the yang in ginseng","volume":"110","author":"Sengupta","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jgr.2025.02.003_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117252","article-title":"Panax Quinquefolium Saponins enhances angiogenesis in rats with diabetes and myocardial infarction","volume":"319","author":"Pan","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jgr.2025.02.003_bib56","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/cvr\/cvq300","article-title":"Ginsenoside-Rg1 induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fibroblast growth factor receptor-1","volume":"89","author":"Cheung","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jgr.2025.02.003_bib57","doi-asserted-by":"crossref","first-page":"36280","DOI":"10.1074\/jbc.M606698200","article-title":"Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase\/Akt and \u03b2-catenin\/T-cell factor-dependent pathway in human endothelial cells","volume":"281","author":"Leung","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jgr.2025.02.003_bib58","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10456-011-9235-z","article-title":"Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1\u03b1 to promote angiogenesis","volume":"14","author":"Leung","year":"2011","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jgr.2025.02.003_bib59","doi-asserted-by":"crossref","first-page":"58072","DOI":"10.18632\/oncotarget.19489","article-title":"MiR-23a targets RUNX2 and suppresses ginsenoside Rg1-induced angiogenesis in endothelial cells","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jgr.2025.02.003_bib60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.taap.2015.06.014","article-title":"Ginsenoside-Rg1 induces angiogenesis by the inverse regulation of MET tyrosine kinase receptor expression through miR-23a","volume":"287","author":"Kwok","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jgr.2025.02.003_bib61","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejps.2009.08.008","article-title":"Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis","volume":"38","author":"Chan","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jgr.2025.02.003_bib62","first-page":"277","article-title":"Ginsenoside Rg1 regulates the secretion of exosomes and the expression of angiogenesis-related miRNAs by endothelial progenitor cells","volume":"33","author":"Xiong","year":"2022","journal-title":"Lishizhen Medicine and Materia Medica Research"},{"key":"10.1016\/j.jgr.2025.02.003_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tem.2023.10.010","article-title":"Regulated cell death in myocardial ischemia-reperfusion injury","volume":"35","author":"Xiang","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jgr.2025.02.003_bib64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jgr.2025.02.003_bib65","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/j.2040-4603.2015.tb00664.x","article-title":"Pathophysiology of myocardial infarction","volume":"5","author":"Frangogiannis","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jgr.2025.02.003_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9121292","article-title":"Oxidative stress and antioxidant treatments in cardiovascular diseases","volume":"9","author":"Wang","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.jgr.2025.02.003_bib67","first-page":"164","article-title":"Effect of ginsenosides-rg1 on acute myocardial ischemic anti-ox idative injury indexes and ultrastructure in experimental rats","volume":"30","author":"Zhang","year":"2015","journal-title":"Chinese Circulation Journal"},{"key":"10.1016\/j.jgr.2025.02.003_bib68","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s12012-022-09767-1","article-title":"Protective effect of ginsenosides Rg1 on ischemic injury of cardiomyocytes after acute myocardial infarction","volume":"22","author":"Yang","year":"2022","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jgr.2025.02.003_bib69","first-page":"4100","article-title":"Protective effect of ginsenoside Rg1 on isoproterenol-induced acute myocardial ischemia in rats","volume":"10","author":"Jin","year":"2017","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib70","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.freeradbiomed.2023.04.015","article-title":"Ginsenoside Rg1 protects cardiac mitochondrial function via targeting GSTP1 to block S-glutathionylation of optic atrophy 1","volume":"204","author":"Zhu","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000484578","article-title":"Ginsenoside Rg1 protects cardiomyocytes against hypoxia\/reoxygenation injury via activation of Nrf2\/HO-1 signaling and inhibition of JNK","volume":"44","author":"Li","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jgr.2025.02.003_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22885","article-title":"Ginsenoside-Rg1 attenuates sepsis-induced cardiac dysfunction by modulating mitochondrial damage via the P2X7 receptor-mediated Akt\/GSK-3\u03b2 signaling pathway","volume":"36","author":"Liu","year":"2022","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.jgr.2025.02.003_bib73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mito.2015.11.003","article-title":"Rg1 prevents myocardial hypoxia\/reoxygenation injury by regulating mitochondrial dynamics imbalance via modulation of glutamate dehydrogenase and mitofusin 2","volume":"26","author":"Dong","year":"2016","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jgr.2025.02.003_bib74","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jgr.2024.02.001","article-title":"Integration of virtual screening and proteomics reveals potential targets and pathways for ginsenoside Rg1 against myocardial ischemia","volume":"48","author":"Xie","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2025.02.003_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00395-016-0549-2","article-title":"Myocardial apoptosis in heart disease: does the emperor have clothes?","volume":"111","author":"Jose Corbalan","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jgr.2025.02.003_bib76","first-page":"465","article-title":"Effects of Ginsenoside Rg1 on arrhythmias induced by ischemic\/reperfusion injury in rats","volume":"33","author":"Shen","year":"2017","journal-title":"Journal of Clinical Cardiology"},{"key":"10.1016\/j.jgr.2025.02.003_bib77","article-title":"Ginsenoside Rg1 ameliorates rat myocardial ischemia-reperfusion injury by modulating energy metabolism pathways","volume":"9","author":"Li","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.jgr.2025.02.003_bib78","doi-asserted-by":"crossref","first-page":"18388","DOI":"10.1002\/jcb.29150","article-title":"Ginsenoside Rg1 protects H9c2 cells against nutritional stress-induced injury via aldolase\/AMPK\/PINK1 signalling","volume":"120","author":"Xu","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jgr.2025.02.003_bib79","first-page":"1096","article-title":"Effect of ginsenoside-rg1 on rat's cardiomyocytes with its mechanism of signal pathway in vitro. Journal of clinical cardiology","volume":"30","author":"Liu","year":"2015","journal-title":"Chinese Circulation Journal"},{"key":"10.1016\/j.jgr.2025.02.003_bib80","first-page":"157","article-title":"Ginsenoside Rg1 inhibits myocardial ischaemia and reperfusion injury via HIF-1\u03b1-ERK signalling pathways in a diabetic rat model","volume":"74","author":"Yuan","year":"2019","journal-title":"Pharmazie"},{"key":"10.1016\/j.jgr.2025.02.003_bib81","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11010-012-1265-3","article-title":"Ginsenoside Rg1 inhibits autophagy in H9c2 cardiomyocytes exposed to hypoxia\/reoxygenation","volume":"365","author":"Zhang","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jgr.2025.02.003_bib82","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12906-016-1112-2","article-title":"Ginsenoside Rg1 protects starving H9c2 cells by dissociation of Bcl-2-Beclin1 complex","volume":"16","author":"Li","year":"2016","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.jgr.2025.02.003_bib83","first-page":"349","article-title":"Ginsenoside Rg1 protects cardiomyocytes from hypoxia-induced injury through the PI3K\/AKT\/mTOR pathway","volume":"73","author":"Qin","year":"2018","journal-title":"Pharmazie"},{"key":"10.1016\/j.jgr.2025.02.003_bib84","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCRESAHA.111.243170","article-title":"Inflammation in myocardial diseases","volume":"110","author":"Marchant","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jgr.2025.02.003_bib85","first-page":"16","article-title":"Ginsenoside Rg1 attenuates myocardial ischemia reperfusion injury through NF-kappaB signaling pathway","volume":"31","author":"He","year":"2015","journal-title":"Pharmacology and Clinics of Chinese Materia Medica"},{"key":"10.1016\/j.jgr.2025.02.003_bib86","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/jcb.29556","article-title":"Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4\/NF-kB\/NLRP3 pathway","volume":"121","author":"Luo","year":"2020","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jgr.2025.02.003_bib87","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jgr.2024.07.003","article-title":"Ginsenoside Rg1 reduces cardiac inflammation against myocardial ischemia\/reperfusion injury by inhibiting macrophage polarization","volume":"48","author":"Xu","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2025.02.003_bib88","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrm3495","article-title":"Molecular basis of physiological heart growth: fundamental concepts and new players","volume":"14","author":"Maillet","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jgr.2025.02.003_bib89","first-page":"55","article-title":"Ginsenoside Rg1 protect cardiac hypertrophy induced by ISO via PGC-1alpha signaling pathway","volume":"31","author":"Wang","year":"2015","journal-title":"Pharmacology and Clinics of Chinese Materia Medica"},{"key":"10.1016\/j.jgr.2025.02.003_bib90","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/FJC.0000000000000410","article-title":"Inhibition of TNF-\u03b1-mediated NF-\u03baB activation by ginsenoside Rg1 contributes the attenuation of cardiac hypertrophy induced by abdominal aorta coarctation","volume":"68","author":"Tang","year":"2016","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jgr.2025.02.003_bib91","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2009.01.048","article-title":"Ginsenoside Rg(1) inhibits rat left ventricular hypertrophy induced by abdominal aorta coarctation: involvement of calcineurin and mitogen-activated protein kinase signalings","volume":"608","author":"Deng","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jgr.2025.02.003_bib92","first-page":"17","article-title":"Ginsenoside Rg1 attenuates the apoptosis of hypertrophic cardiomyocyte via calpain-1 signaling pathway","volume":"33","author":"Yang","year":"2017","journal-title":"Pharmacology and Clinics of Chinese Materia Medica"},{"key":"10.1016\/j.jgr.2025.02.003_bib93","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/FJC.0b013e31828f8d45","article-title":"The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis","volume":"62","author":"Zhang","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jgr.2025.02.003_bib94","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","article-title":"Evolving therapies for myocardial ischemia\/reperfusion injury","volume":"65","author":"Ib\u00e1\u00f1ez","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jgr.2025.02.003_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202200730","article-title":"Ginsenoside Rg1 protects against cardiac remodeling in heart failure via SIRT1\/PINK1\/parkin-mediated mitophagy","volume":"20","author":"Guan","year":"2023","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.jgr.2025.02.003_bib96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2047-783X-18-16","article-title":"The effects and mechanism of ginsenoside Rg1 on myocardial remodeling in an animal model of chronic thromboembolic pulmonary hypertension","volume":"18","author":"Li","year":"2013","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jgr.2025.02.003_bib97","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jgr.2021.03.006","article-title":"Ginsenoside Rg1 attenuates mechanical stress-induced cardiac injury via calcium sensing receptor-related pathway","volume":"45","author":"Lu","year":"2021","journal-title":"Journal of Ginseng Research"},{"key":"10.1016\/j.jgr.2025.02.003_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110915","article-title":"Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: pharmacology and mechanisms","volume":"132","author":"Fan","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jgr.2025.02.003_bib99","article-title":"Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jgr.2025.02.003_bib100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jgr.2021.07.008","article-title":"Recent progress (2015-2020) in the investigation of the pharmacological effects and mechanisms of ginsenoside Rb1, a main active ingredient in Panax ginseng Meyer","volume":"46","author":"Lin","year":"2022","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2025.02.003_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116111","article-title":"A promising target for ischemia-reperfusion injury therapy (A mini review)","volume":"171","author":"Feng","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jgr.2025.02.003_bib102","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.apsb.2016.05.001","article-title":"Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC-MS\/MS: rg1 excretion in rat bile, urine and feces","volume":"6","author":"He","year":"2016","journal-title":"Acta Pharm Sin B"}],"container-title":["Journal of Ginseng Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845325000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845325000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:31:42Z","timestamp":1762367502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1226845325000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1226845325000247"],"URL":"https:\/\/doi.org\/10.1016\/j.jgr.2025.02.003","relation":{},"ISSN":["1226-8453"],"issn-type":[{"value":"1226-8453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles and mechanisms of ginsenoside Rg1 in coronary artery disease: Progress and perspectives","name":"articletitle","label":"Article Title"},{"value":"Journal of Ginseng Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgr.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Korean Society of Ginseng. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}